| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.08. | Custom Health Holdings Inc: Custom Health enters deal to acquire Spencer Health | 1 | Stockwatch | ||
| 05.08. | Custom Health Holdings Inc.: Custom Health to Acquire Spencer Health Solutions, Strengthening Its Medication Management Infrastructure at Home | 589 | Newsfile | Custom Health has entered into a definitive agreement to acquire Spencer Health Solutions, which is expected to unite Custom Health's pharmacist-led medication management platform with the spencer... ► Artikel lesen | |
| CUSTOM HEALTH Aktie jetzt für 0€ handeln | |||||
| 22.07. | Custom Health Holdings Inc: Custom Health agrees to buy Evergreen pharmacy | 1 | Stockwatch | ||
| 22.07. | Stocks in Play: Custom Health Holdings Inc | 1 | Baystreet.ca | ||
| 22.07. | Custom Health to acquire Evergreen Pharmacy for $3.5M | 3 | Seeking Alpha | ||
| 22.07. | Custom Health Holdings Inc.: Custom Health Announces Binding Letter of Intent to Acquire Evergreen Pharmacy; Expected to Add Over US$78 Million in Annual Revenue | 521 | Newsfile | Custom Health has entered into a binding letter of intent (the "LOI") to acquire Evergreen Pharmacy LLC ("Evergreen"), a Wisconsin-based specialty pharmacy specializing in the management of complex... ► Artikel lesen | |
| 08.07. | Custom Health: Delivering Healthcare Through AI-Enabled Technology | 1 | The Market Online Canada | ||
| 03.07. | Custom Health Holdings Inc: Custom Health loses $8.05-million (U.S.) in Q1 | 3 | Stockwatch | ||
| 03.07. | Stocks in Play: Custom Health Holdings Inc. | 1 | Baystreet.ca | ||
| 03.07. | Custom Health Holdings Inc.: Custom Health Delivers US$51.6 Million Proforma Annualized Revenue Run-Rate in Q1-2026 | 692 | Newsfile | For the three months ended March 31, 2026, Custom Health achieved quarterly revenue of US$4.3 million, while InnovativeRx (as defined below) achieved record quarterly revenue of US$8.6 million,... ► Artikel lesen | |
| 25.06. | Custom Health Holdings Inc: Custom Health appoints Guzman chief compliance officer | 1 | Stockwatch | ||
| 25.06. | Custom Health Holdings Inc.: Custom Health Announces Strategic Leadership Appointments to Support Continued Growth and Regulatory Excellence | 449 | Newsfile | Robert Guzman has been appointed Chief Compliance & Regulatory Officer, bringing extensive experience in regulatory oversight, compliance management, and quality assurance to strengthen Custom Health's... ► Artikel lesen | |
| 23.06. | Custom Health Holdings Inc: Custom Health Holdings to trade on TSX | 1 | Stockwatch | ||
| 23.06. | Custom Health Holdings Inc: Custom Health Holdings to trade on TSX June 24 | 1 | Stockwatch | ||
| 22.06. | Custom Health Holdings Inc.: Custom Health Holdings Inc. to Commence Trading on the Toronto Stock Exchange | 1.181 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - Custom Health Holdings Inc. (TSX: CHLT) (formerly, Queue Ventures Ltd.) ("Custom Health" or the "Company"), further to its press release... ► Artikel lesen | |
| 10.06. | Custom Health Holdings Inc.: Custom Health Announces Closing of the Acquisition of InnovativeRx Operating Subsidiaries to Expand Integrated Medication Management Infrastructure Across North America | 695 | Newsfile | Strategic Acquisition: Custom Health announces the closing of the acquisition of substantially all of the operating assets of InnovativeRx US Holdings, Inc. ("InnovativeRx") to expand its integrated... ► Artikel lesen | |
| 09.06. | Kevin Knight: Kevin Knight - Early Warning Regarding Acquisition of Common Shares of Custom Health Holdings Inc | 298 | Newsfile | This press release is issued pursuant to National Instrument 62-104 - Take-Over Bids and Issuer Bids and National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider... ► Artikel lesen | |
| 06.06. | Custom Health Holdings Inc. Announces Completion of Plan of Arrangement | 928 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Custom Health Holdings Inc. (formerly, Queue Ventures Ltd.) ("Custom Health" or the "Company"), further to its press release dated May... ► Artikel lesen | |
| 14.05. | Custom Health Inc. Announces Appointment of Chief Financial Officer and Board of Directors and Shareholder Approval for Proposed Public Listing | 335 | Newsfile | Jason Nalewany has been appointed as Chief Financial Officer of Custom Health and, following the completion of the Arrangement, the Resulting Issuer. Jason will support both companies by providing... ► Artikel lesen | |
| 08.04. | Custom Health Inc. to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference | 462 | Newsfile | Kelowna, British Columbia--(Newsfile Corp. - April 8, 2026) - Custom Health Inc. ("Custom Health" or the "Company"), a vertically integrated, tech-enabled care platform, is pleased to announce that... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 42,110 | +0,07 % | Heartflow, Inc.: Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results... ► Artikel lesen | |
| FRESENIUS | 47,080 | -1,22 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius von 57 auf 58 Euro angehoben und die Einstufung auf "Kaufen" belassen. Analyst Sven Kürten lobte in seinem Resümee... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,310 | +0,69 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,040 | +0,12 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,310 | -0,08 % | Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,280 | +6,04 % | GOLDMAN SACHS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Carl Zeiss Meditec von 28 auf 27 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Analyst Richard Felton... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,73 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 26,280 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,950 | -0,07 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,415 | 0,00 % | LifeStance Health gains as Hedgeye adds as new long idea | ||
| SANARA MEDTECH | 34,140 | -0,03 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| BILLIONTOONE | 93,34 | +0,01 % | Diagnostiksektor: BTIG kürt BillionToOne zum Top-Pick | ||
| BETA BIONICS | 17,570 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GERRESHEIMER | 27,160 | +0,97 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| GENEDX | 78,16 | +0,10 % | GeneDx launches online exome testing for pediatric patients |